Deep Venous Thromboembolism
The incidence of deep vein thrombosis (DVT) following musculoskeletal foot and ankle surgery is in the range of 1% – 23%. Surveys completed by American and British foot and ankle surgeons have documented wide variability in current VTE practice, including choice of medication, duration, and alternative treatment options. Such confusion underscores the need for better data to optimize patient safety during the management of VTE prevention in patients following musculoskeletal foot or ankle surgery. In hip or knee surgery, where rates of DVT can reach up to 60% without preventative measures, prophylaxis is far more easily justifiable. Although DVT rates may be lower in aggregate among the foot and ankle surgical population, limited data already exist to suggest that certain subsets of foot and ankle patients, such as those with Achilles ruptures, may have DVT rates surpassing one-third of patients. These subsets should be identified to responsibly treat those at high risk while also minimizing the risk for patients for whom prophylaxis is unnecessary.
FARIL team has published numerous papers regarding DVT, specifically in foot and ankle patients. However, the need for better predictive protocols as well as management methods has still remained. Our team welcomes ideas, suggestions, and collaboration opportunities with open arms.